Skip to main content
Clinical Trials/CTRI/2023/07/055127
CTRI/2023/07/055127Not yet recruitingPhase 3

Evaluation of Efficacy of ashwagandadi guggulu and simhanada guggulu with erandamooladi kshara basti and valuka sweda in Amavata vis-a-vis Rheumatoid arthritic An open label randomized comparative clinical study - NI

Dr Venkatesh R0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Subjects who fulfil diagnostic criteria of Amavata & Rheumatoid arthritis, irrespective of gender, religion, occupation and socio-economic status.
  • Age group between 18-60years, fit for Basti and willing to sign informed consent.
  • Diagnosed cases of Rheumatoid arthritis, with or without conventional medication.

Exclusion Criteria

  • Subjects with other systemic diseases which would interfere the present study such as Diabetes mellitus, CAD,CKD.
  • Subjects who have developed other connective tissue disorders or any Autoimmune disorder such as Osteoarthritis, SLE, Gouty Arthritis.
  • Pregnant women and Lactating mother.

Investigators

Sponsor
Dr Venkatesh R

Similar Trials